Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2B | Q13224 | 5/20 | 0.55 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.55 |
| ▸ | DRD2 | P14416 | 8/20 | 0.48 |
| ▸ | DRD1 | P21728 | 4/20 | 0.48 |
| ▸ | DRD3 | P35462 | 4/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | THPO | P40225 | 1/20 | 0.48 |
| ▸ | DRD4 | P21917 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7327800 | 0.99 | GRIN2B (0.54) | GRIN2BGRIN1DRD2DRD1DRD3 | |
| SCHEMBL7327607 | 0.96 | GRIN2B (0.54) | GRIN2BGRIN1DRD2DRD1DRD3 | |
| SCHEMBL7325610 | 0.92 | DRD2 (0.54) | GRIN2BGRIN1DRD2DRD1DRD3 | |
| SCHEMBL7328536 | 0.90 | GRIN2B (0.49) | GRIN2BGRIN1DRD2DRD1DRD3 | |
| SCHEMBL7329812 | 0.89 | GRIN2B (0.48) | GRIN2BGRIN1DRD2DRD1DRD3 | |
| SCHEMBL7329980 | 0.87 | GRIN2B (0.49) | GRIN2BGRIN1DRD2DRD3 | |
| SCHEMBL7326705 | 0.86 | GRIN2B (0.48) | GRIN2BGRIN1DRD2DRD1DRD3 | |
| SCHEMBL7337152 | 0.86 | GRIN2B (0.55) | GRIN2BDRD2DRD1DRD3CYP1A2 | |
| SCHEMBL7327286 | 0.86 | GRIN2B (0.48) | GRIN2BGRIN1DRD2DRD3 | |
| SCHEMBL7333909 | 0.86 | DRD2 (0.52) | GRIN2BGRIN1DRD2DRD1DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0402923-A2 | 2,5-Diaminotetralines, process for their preparation and their use as medicine | BOEHRINGER INGELHEIM KG (DE) | 1990-12-19 | — | — | EP | disclosed |